Home Categories API Balofloxacin
A1413712

Balofloxacin , 98% , 127294-70-6

Synonym(s):
(±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)piperidino]-4-oxo-3-quinolinecarboxylic acid

CAS NO.:127294-70-6

Empirical Formula: C20H24FN3O4

Molecular Weight: 389.42

MDL number: MFCD00864925

EINECS: 1312995-182-4

Pack Size Price Stock Quantity
100MG RMB302.40 In Stock
500MG RMB749.60 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 137°C
Boiling point: 608.3±55.0 °C(Predicted)
Density  1.40±0.1 g/cm3(Predicted)
storage temp.  Keep in dark place,Inert atmosphere,2-8°C
solubility  H2O : < 0.1 mg/mL (insoluble)DMSO : 0.67 mg/mL (1.72 mM; Need ultrasonic)
form  Solid
pka 6.44±0.50(Predicted)
color  White to off-white
BRN  8362117
CAS DataBase Reference 127294-70-6(CAS DataBase Reference)

Description and Uses

Balofloxacin, a novel orally-active fluoroquinolone antibiotic, was introduced in South Korea for the treatment of urinary tract infections (UTI). It can be synthetized by reaction of 3-(methylamino)piperidine with the classical 4-quinolone-3-carboxylic acid template. In vitro antibacterial activity of balofloxacin against gram-positive bacteria (Staphylococcus aureus including methicillin-resistant S. aureus, Staphylococcus epidermis, Streptococcus pneumonia, Streptococcus pyrogenes) was almost equal to that of sparfloxacin or tosufloxacin, in contrast its activity against gram-negative bacteria was 2 times or more lower. In clinical trials, balofloxacin was well tolerated and showed comparable efficacy to ofloxacin in patients with UTls. After oral administration, balofloxacin was well absorbed, and was primarily eliminated unchanged in the urine with an elimination half-life of approximately 8 h. In animal studies, balofloxacin did not exhibit any phototoxicity.

Fluorinated quinolone antibacterial.

Safety

Symbol(GHS) 
GHS02
Signal word  Warning
Hazard statements  H228
Precautionary statements  P403-P501c
WGK Germany  3

RELATED PRODUCTS